1) 日本高血圧学会高血圧治療ガイドライン作成委員会:高血圧ガイドライン 2004年版,日本高血圧学会,2004
2) Kario K, et al:Morning blood pressure surge and hypertensive cerebrovascular disease. Am J Hypertens 17:668-675, 2004
3) Kario K, et al:Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation 107:1401-1406, 2003
4) Kamoi K, et al:The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes; Evaluation using home-based blood pressure measurements. Clin Exp Hypertens 27:369-376, 2005
5) Yoshinari M, et al:Orthostatic hypertension in patients with type 2 diabetes. Diabetes Care 24:1783-1786, 2001
6) Kario K, et al:U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives. J Am Coll Cardiol 40:133-141, 2002
7) Andersson PE, et al:Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity. J Hum Hypertens 8:219-226, 1994
8) Derosa G, et al:Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type2 diabetes and hypertension. J Cardiovasc Pharmacol 45:599-604, 2005
9) Neaton JD, et al:Treatment of mild hypertension study;Final results. JAMA 270:713-724, 1993
10) Levy D, et al:Principal results of the hypertension and lipid trial(HALT);A multicenter study of doxazosin in patients with hypertension. Am Heart J 131:966-973, 1996
11) Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.:Diuretic versus alpha-blocker as first-step antihypertensive therapy:Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial(ALLHAT). Hypertension 42:239-246, 2003
12) 後藤由夫・他:高コレステロール血症および糖尿病の一方または双方を合併した本態性高血圧症に対するメシル酸ドキサゾシンの長期効果の検討.日臨内医会誌 16:46-67, 2001